Legal & General Group’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $9.4M | Buy |
68,393
+1,884
| +3% | +$259K | ﹤0.01% | 1224 |
|
2025
Q1 | $12M | Sell |
66,509
-2,916
| -4% | -$526K | ﹤0.01% | 1046 |
|
2024
Q4 | $10.9M | Buy |
69,425
+3,170
| +5% | +$497K | ﹤0.01% | 1121 |
|
2024
Q3 | $12.1M | Buy |
66,255
+1,666
| +3% | +$303K | ﹤0.01% | 1072 |
|
2024
Q2 | $11.9M | Buy |
64,589
+45,039
| +230% | +$8.27M | ﹤0.01% | 1040 |
|
2024
Q1 | $3.48M | Buy |
19,550
+458
| +2% | +$81.5K | ﹤0.01% | 1689 |
|
2023
Q4 | $2.37M | Sell |
19,092
-435
| -2% | -$54K | ﹤0.01% | 1867 |
|
2023
Q3 | $2.27M | Buy |
19,527
+821
| +4% | +$95.2K | ﹤0.01% | 1846 |
|
2023
Q2 | $2.2M | Buy |
18,706
+9,457
| +102% | +$1.11M | ﹤0.01% | 1886 |
|
2023
Q1 | $740K | Buy |
9,249
+2,129
| +30% | +$170K | ﹤0.01% | 2223 |
|
2022
Q4 | $564K | Buy |
7,120
+155
| +2% | +$12.3K | ﹤0.01% | 2305 |
|
2022
Q3 | $485K | Buy |
6,965
+387
| +6% | +$26.9K | ﹤0.01% | 2357 |
|
2022
Q2 | $431K | Buy |
6,578
+45
| +0.7% | +$2.95K | ﹤0.01% | 2380 |
|
2022
Q1 | $435K | Buy |
6,533
+370
| +6% | +$24.6K | ﹤0.01% | 2432 |
|
2021
Q4 | $432K | Buy |
6,163
+568
| +10% | +$39.8K | ﹤0.01% | 2457 |
|
2021
Q3 | $293K | Buy |
5,595
+2,816
| +101% | +$147K | ﹤0.01% | 2573 |
|
2021
Q2 | $189K | Buy |
2,779
+109
| +4% | +$7.41K | ﹤0.01% | 2547 |
|
2021
Q1 | $206K | Buy |
2,670
+281
| +12% | +$21.7K | ﹤0.01% | 2450 |
|
2020
Q4 | $144K | Hold |
2,389
| – | – | ﹤0.01% | 2487 |
|
2020
Q3 | $102K | Sell |
2,389
-355
| -13% | -$15.2K | ﹤0.01% | 2483 |
|
2020
Q2 | $113K | Buy |
2,744
+273
| +11% | +$11.2K | ﹤0.01% | 2494 |
|
2020
Q1 | $107K | Sell |
2,471
-469
| -16% | -$20.3K | ﹤0.01% | 2391 |
|
2019
Q4 | $163K | Buy |
2,940
+414
| +16% | +$23K | ﹤0.01% | 2448 |
|
2019
Q3 | $88K | Buy |
2,526
+1,066
| +73% | +$37.1K | ﹤0.01% | 2562 |
|
2019
Q2 | $59K | Buy |
+1,460
| New | +$59K | ﹤0.01% | 2705 |
|